【レポートの概要（一部）】
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Helicobacter Pylori Infections 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Helicobacter Pylori Infections to Infectious Disease Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Helicobacter Pylori Infections to Infectious Disease Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Helicobacter Pylori Infections 25
Subjects Recruited Over a Period of Time 28
Clinical Trials by Sponsor Type 29
Prominent Sponsors 30
Top Companies Participating in Helicobacter Pylori Infections Therapeutics Clinical Trials 31
Prominent Drugs 32
Latest Clinical Trials News on Helicobacter Pylori Infections 33
Jun 08, 2015: RedHill Biopharma Completes Treatment of Last Patient with RHB-105 in Phase III Study 33
Jun 03, 2015: RedHill Biopharma Provides Update on Development Pipeline and Expected Timing for RHB-105 Phase III Top-Line Results 33
May 07, 2015: RedHill Biopharma to Host Investor Webcast Forum Following Completion of RHB-105 Dosing in Phase III Study 35
Apr 27, 2015: RedHill Biopharma Announces Completion of Patient Enrollment in a Phase III Study of RHB-105 for H. pylori Infection 35
Clinical Trial Profiles 37
Clinical Trial Overview of Top Companies 37
RedHill Biopharma Ltd. 37
Clinical Trial Overview of RedHill Biopharma Ltd. 37
AstraZeneca Plc 38
Clinical Trial Overview of AstraZeneca Plc 38
MerLion Pharmaceuticals Pte Ltd 39
Clinical Trial Overview of MerLion Pharmaceuticals Pte Ltd 39
Aspen Pharmacare Holdings Ltd 40
Clinical Trial Overview of Aspen Pharmacare Holdings Ltd 40
Takeda Pharmaceutical Company Limited 41
Clinical Trial Overview of Takeda Pharmaceutical Company Limited 41
Otsuka Holdings Co., Ltd. 42
Clinical Trial Overview of Otsuka Holdings Co., Ltd. 42
Eisai Co., Ltd. 43
Clinical Trial Overview of Eisai Co., Ltd. 43
Forest Laboratories, Inc. 44
Clinical Trial Overview of Forest Laboratories, Inc. 44
Chemo Espana, S.A. 45
Clinical Trial Overview of Chemo Espana, S.A. 45
Bluefish Pharmaceuticals AB 46
Clinical Trial Overview of Bluefish Pharmaceuticals AB 46
Clinical Trial Overview of Top Institutes / Government 47
National Taiwan University Hospital 47
Clinical Trial Overview of National Taiwan University Hospital 47
Tehran University of Medical Sciences 48
Clinical Trial Overview of Tehran University of Medical Sciences 48
Mazandaran University of Medical Sciences 49
Clinical Trial Overview of Mazandaran University of Medical Sciences 49
Keio University 50
Clinical Trial Overview of Keio University 50
Shanghai Jiao Tong University School of Medicine 51
Clinical Trial Overview of Shanghai Jiao Tong University School of Medicine 51
Buddhist Tzu Chi General Hospital 52
Clinical Trial Overview of Buddhist Tzu Chi General Hospital 52
Guilan University of Medical Sciences 53
Clinical Trial Overview of Guilan University of Medical Sciences 53
Kaohsiung Veterans General Hospital. 54
Clinical Trial Overview of Kaohsiung Veterans General Hospital. 54
The University of Tokyo Hospital 55
Clinical Trial Overview of The University of Tokyo Hospital 55
National Cancer Center 56
Clinical Trial Overview of National Cancer Center 56
Five Key Clinical Profiles 57
Appendix 75
Abbreviations 75
Definitions 75
Research Methodology 76
Secondary Research 76
About GlobalData 77
Contact Us 77
Disclaimer 77
Source 77
【レポート販売概要】
■ タイトル：ヘリコバクター・ピロリ感染症：世界の治験レビュー（2015年上半期版）■ 英文：Helicobacter Pylori Infections Global Clinical Trials Review, H1, 2015
■ 発行日：2015年6月16日
■ 調査会社：GlobalData
■ 商品コード：GDHC2732CTIDB
■ 調査対象地域：グローバル
- ドアクローザの世界市場2017-2021The door closer market has been witnessing growth across regions due to the increasing awareness of high-tech security systems among various end-users and easy operations of such equipment. Also, there has been an impact in the market due to the deployment of smart solutions in the developed and developing economies. Also, the major reason that drives the market is the increasing security concerns …
- 横紋筋肉腫(Rhabdomyosarcoma)：治療薬開発パイプライン動向（2015年上半期版）Rhabdomyosarcoma - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Rhabdomyosarcoma - Pipeline Review, H1 2015’, provides an overview of the Rhabdomyosarcoma’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Rhabdomyosarcoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of …
- 鉛電池の世界市場2015-2019Market outlook of the global lead-acid battery market Lead-acid batteries are rechargeable devices that are comprised of lead electrodes submerged in diluted sulfuric acid. The global market for lead-acid batteries is estimated to show steady growth during the forecast period and factors like the rising use of lead-acid batteries by various end-user segments and other motive applications such as f …
- ウィスキーの世界市場：スコッチウィスキー、アメリカンウィスキー、カナディアンウィスキー、アイリッシュウィスキー、その他Global Whiskey Market: About this market Whiskey is an alcoholic beverage, which is distilled from malted grains such as rye, corn, or barley. Technavio’s whiskey market analysis considers sales from the Scotch whiskey, American whiskey, Canadian whiskey, Irish whiskey, and other segments. The sales are made through off-trade and on-trade distribution channels. Our analysis also considers the sale …
- Rituxan (Systemic Lupus Erythematosus and Lupus Nephritis)：市場予測と分析（～2022）Rituxan (Systemic Lupus Erythematosus and Lupus Nephritis) - Forecast and Market Analysis to 2022 Summary Systemic lupus erythematosus (SLE) is a systemic inflammatory autoimmune disease that can affect any organ or tissue and is the prototypic autoimmune disease. While SLE can affect multiple major organ systems in the body, one of its most severe manifestations includes renal (kidney) involvemen …
- プリンテッドエレクトロニクスの世界市場予測（～2023年）“Printed electronics market to grow at CAGR of 14.92% from 2018 to 2023”The printed electronics market is estimated to reach USD 13.6 billion by 2023 from USD 6.8 billion in 2018, at a CAGR of 14.92% during 2018–2023. Printed electronics is gaining high traction worldwide owing to the rise in the application of printed electronics in the Internet of Things (IoT). The high demand for thin, robust, …
- 動物用ワクチンの世界市場予測：製品、疾患、技術、地域別分析The global animal vaccines market is poised to reach USD 7.68 Billion by 2021 from USD 5.81 Billion in 2016, at a CAGR of 5.8% from 2016 to 2021. The increase in livestock population and repeated breakouts of livestock diseases; increasing incidence of zoonotic diseases; initiatives by various government agencies, animal associations, and leading players; and the introduction of new vaccine types …
- 冠動脈狭窄：治療薬の治験動向（2014年下半期）Coronary Stenosis Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Coronary Stenosis Global Clinical Trials Review, H2, 2014" provides data on the Coronary Stenosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Coronary Stenosis. It includes an overview of the trial numbers and their recruitment s …
- 代替燃料の世界市場2018-2022108 pages, November 2018 About this market The transportation sector has been one of them major sources of air pollution globally. The combustion of fossil fuels releases emission such as carbon dioxide which is one of the major contributor of GHG emissions. As GHG’s have a negative effect on ecosystem and therefore, the government across globe have decided to decarbonize the transportation sector …
- コイルドチュービングサービスの世界市場：ウェルインターベンション、掘削サービスThis report estimates the coiled tubing market in terms of value in $Million. This has been segmented into component regions and further split into countries. A Coil Tubing (CT) unit usually comprises a set of equipment to perform standard continuous-length tubing operations in the oil & gas fields. Coiled tubes are generally made of low-alloy carbon-steel and range from 0.75 inches to 4 inches in …
- 不妊治療サービスの米国市場2017-2021About Infertility Services Infertility is the failure to achieve pregnancy after 12 months of unprotected intercourse. Infertility occurs due to the abnormal functioning of the female and male reproductive system. It can be treated with infertility drugs and through procedures such as artificial insemination, in-vitro fertilization, and surrogacy. Technavio’s analysts forecast the infertility serv …
- 世界の口腔衛生市場動向（2012-2016）TechNavio's analysts forecast the Global Oral Hygiene market to grow at a CAGR of 3.14 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing awareness of oral hygiene. The Global Oral Hygiene market has also been witnessing an increasing demand for natural and organic oral hygiene products. However, the low priority placed on oral health cou …
- 心室頻拍：グローバル臨床試験レビューH2, 2013Ventricular Tachycardia Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Ventricular Tachycardia Global Clinical Trials Review, H2, 2013" provides data on the Ventricular Tachycardia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Ventricular Tachycardia. It includes an overview of the trial numbers …
- ラボラトリーオートメーション装置/ソフトウェアの世界市場：ロボットアーム、マイクロプレートリーダー、LIMS（ラボ情報管理システム）The report segments the lab automation market on the basis of equipment and software, application, type of automation, end user, and region. On the basis of applications, the lab automation market is broadly classified into clinical diagnostics, drug discovery, genomics solutions, and proteomics solutions. Drug discovery is a major application of the lab automation market. Developing markets such …
- 世界のシステム・インフラ・ソフト市場（2012-2016）TechNavio's analysts forecast the Global System Infrastructure Software market to grow at a CAGR of 5.24 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing adoption of mobile devices. The Global System Infrastructure Software market has also been witnessing the increasing adoption of cloud-based system infrastructure software. However, th …
